Cargando…
Antibody drug conjugates: hitting the mark in pancreatic cancer?
Pancreatic cancer is one of the most common causes of cancer-related death, and the 5-year survival rate has only improved marginally over the last decade. Late detection of the disease means that in most cases the disease has advanced locally and/or metastasized, and curative surgery is not possibl...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598980/ https://www.ncbi.nlm.nih.gov/pubmed/37880707 http://dx.doi.org/10.1186/s13046-023-02868-x |